Original language | English |
---|---|
Journal | Journal of the European Academy of Dermatology and Venereology : JEADV |
Volume | 35 |
Issue number | 11 |
Pages (from-to) | e709-e711 |
ISSN | 0926-9959 |
DOIs | |
Publication status | Published - 11.2021 |
Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials
D Thaçi, D Jullien, A Egeberg, J M Carrascosa, J J Wu, I Pau-Charles, P Gisondi
- Department of Dermatology
- Edouard Herriot Hospital
- Copenhagen University Hospital Bispebjerg
- Germans Trias i Pujol University Hospital (HUGTP)
- Autonomous University of Barcelona (UAB)
- Dermatology Research and Education Foundation
- UC Irvine
- Children's Hospital Central California
- Almirall R and D
- Barcelona-Tech
- AstraZeneca Global Medical Affairs, Spain.
- Department of Medicine III
- University of Verona